Mahindra & Mahindra, Rallis India, Reliance Industries may see action

Mahindra & Mahindra will reportedly spend around Rs 2000 crore to augment capacity at its Chakan plant that is expected to be operational in October 2009, as it looks to crack the US car market that accounts for more than a fifth of all cars sold globally.

The Tata Group is reportedly considering merging pesticide maker Rallis India with Tata Chemicals. The marger targets a 15-20% cut in Rallis' raw material, staff, logistics and other operational costs.

Reliance Industries is reportedly looking to sell 15% in Rewas Port in Maharashtra to fund the project as well as to bring in specialists as it does not have expertise in handling cargo.

Real estate developer DLF is reportedly set to bag a 350.71-acre land parcel in Gurgaon for Rs 1703 crore, after it emerged the sole bidder for the land put up for auction by the Haryana government.

The Delhi High Court has reportedly dismissed German drug major Bayer's attempt to stop the Drug Controller General of India (DCGI) from giving marketing approval to India's Cipla for the generic version of the former's patented kidney cancer drug, Nexavar. Besides, it has asked the German firm to pay Rs 6.75 lakh to the government and Cipla as legal cost.

Daiichi Sankyo Co, which owns India's Ranbaxy Labs is reported to be in early talks with Lupin for a product marketing parternship.

Aditya Birla Nuvo is reportedly expecting equity infusion of about Rs 600 crore from founder Kumar Mangalam Birla in the current financial year in the form of warrant conversion. Another Rs 400 crore is expected in the next financial year.

United Spirits has reportedly initiated talks with more than half-a-dozen private equity firms to raise over $300 million to develerage its